The Centers for Medicare and Medicaid Services (CMS) has released its proposed rule for the 2027 Outpatient Prospective Payment System (OPPS). This rule details planned changes to payment rates, policies, and quality programs that will affect hospitals, health systems, and other healthcare providers. The proposed rule aims to update how Medicare pays for outpatient services and implements several policy shifts.

Key Takeaways

  • CMS proposes updating OPPS payment rates for 2027 with specific adjustments for inflation and other factors.
  • The rule includes changes to the hospital outpatient quality reporting program and the outpatient quality star ratings.
  • New policies address hospital price transparency requirements and the 340B drug discount program.
  • Several provisions aim to streamline payment for innovative technologies and services.

Payment Rate Updates and Adjustments

The 2027 OPPS proposed rule includes updates to standard payment rates for hospital outpatient services. According to the original report from Buchanan Ingersoll & Rooney PC, CMS projects that total payments to OPPS providers will increase by a certain percentage compared to the current year, driven largely by the market basket update and other statutory adjustments. The rule also outlines changes to the patient copayment amounts for outpatient services under Part B.

CMS proposes to continue using its standard methodology for calculating payment rates under OPPS. This includes applying budget neutrality adjustments and accounting for expected changes in utilization and case mix. The rule also addresses outlier payments for high-cost services and the supervision requirements for outpatient therapeutic services.

Quality Reporting Program Changes

The proposed rule introduces updates to the Hospital Outpatient Quality Reporting (OQR) program. CMS plans to remove some existing quality measures and add new ones that align with current clinical priorities. The agency also proposes to modify how it calculates and displays outpatient quality star ratings on the Hospital Compare website. These changes aim to provide clearer information to patients while reducing administrative burden on hospitals.

CMS is seeking public comment on several aspects of the OQR program, including the timeline for adopting electronic clinical quality measures. The rule also outlines requirements for data validation and the consequences for hospitals that fail to meet reporting deadlines.

Price Transparency and Consumer Information

Building on previous efforts to improve price transparency, the 2027 OPPS proposed rule includes new requirements for how hospitals display their charges and negotiated rates. CMS proposes to update the machine readable file format standards and require more detailed information about services and payer specific negotiated rates. Noncompliance penalties would also be adjusted under the new rule.

The proposed rule also addresses how hospitals must make their standard charges public. CMS emphasizes the importance of providing accurate and up to date pricing data to help patients make informed decisions about their care.

340B Drug Discount Program Implications

The 2027 OPPS proposed rule continues ongoing policy discussions regarding the 340B Drug Pricing Program. CMS outlines how it will handle payments for drugs acquired under the 340B program, including potential rate adjustments. The agency also addresses the question of whether certain 340B acquired drugs should be paid at lower rates compared to non 340B drugs. The rule seeks comments on how best to ensure the program remains financially neutral for both hospitals and the Medicare program.

Innovation and Technology Policies

CMS proposes several changes to encourage the adoption of innovative medical technologies in the outpatient setting. The rule includes pathways for new devices and diagnostics to receive special payment designation, which can help speed patient access to cutting edge treatments. The agency also provides updates to its current list of covered outpatient drugs and biological products, including new drug administration codes and payment adjustments.

The proposed rule addresses how Medicare will pay for certain cell and gene therapies, as well as digital health products, when services are provided in hospital outpatient departments. CMS is also seeking feedback on mechanisms to support value based payment arrangements related to outpatient care.

Frequently Asked Questions

What is the timeline for the 2027 OPPS proposed rule?

The proposed rule was released by CMS and is subject to a public comment period. Following review of comments, CMS will publish a final rule later this year. The final policy changes will take effect on January 1, 2027, for hospital outpatient services.

How will the 2027 OPPS proposed rule affect hospital reimbursement?

The rule includes an update to the base payment rate for outpatient services, which will increase total Medicare payments to OPPS providers, according to the original report. However, individual hospitals may see different impacts depending on their service mix, case complexity, and compliance with quality reporting programs. Changes to the 340B program and price transparency requirements could also affect overall reimbursement levels for some facilities.

What should hospitals do now to prepare for the 2027 OPPS changes?

Hospitals should review the proposed rule carefully and consider submitting comments to CMS before the deadline. The original report recommends that healthcare providers assess how the proposed payment changes, quality measure updates, and transparency mandates will affect their operations. Hospitals may also need to update their compliance procedures and billing systems to align with the anticipated new requirements.

This is an original report by Vital Signs Today, informed by reporting from Google News. Read the original source.

This article is for information only and is not medical advice. See our Medical Disclaimer.